Development of Drug Delivery and Photoactivation Devices for the Treatment of Bladder Cancer

18 September 2023 13:45 - 14:15

  • Performing front end research to understand the clinical environment for administering combination product therapy.
  • Defining device development requirements based on the limitations of clinical and drug product characteristics.
  • Importance of obtaining early user feedback on device prototypes and procedures.
  • Strategies for device sourcing and testing to speed evaluation of combination products in clinical trials.

Keith Faucher, Senior Director Device Development and Innovation, Aura Biosciences